WORK MEDICAL TECHNOLOGY GR-A (WOK) Fundamental Analysis & Valuation

NASDAQ:WOK • KYG9767H1258

Current stock price

1.14 USD
+0.03 (+2.7%)
Last:

This WOK fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. WOK Profitability Analysis

1.1 Basic Checks

  • WOK had negative earnings in the past year.
WOK Yearly Net Income VS EBIT VS OCF VS FCFWOK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

  • WOK has a Return On Assets (-10.67%) which is in line with its industry peers.
  • WOK has a Return On Equity of -28.62%. This is comparable to the rest of the industry: WOK outperforms 54.89% of its industry peers.
Industry RankSector Rank
ROA -10.67%
ROE -28.62%
ROIC N/A
ROA(3y)-1.96%
ROA(5y)N/A
ROE(3y)-5.57%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
WOK Yearly ROA, ROE, ROICWOK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

  • WOK has a worse Gross Margin (26.88%) than 78.80% of its industry peers.
  • WOK's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for WOK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.88%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.79%
GM growth 5YN/A
WOK Yearly Profit, Operating, Gross MarginsWOK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. WOK Health Analysis

2.1 Basic Checks

  • WOK does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for WOK has been increased compared to 1 year ago.
  • The debt/assets ratio for WOK is higher compared to a year ago.
WOK Yearly Shares OutstandingWOK Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 500 1K
WOK Yearly Total Debt VS Total AssetsWOK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • WOK has an Altman-Z score of 0.25. This is a bad value and indicates that WOK is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.25, WOK is in line with its industry, outperforming 44.02% of the companies in the same industry.
  • A Debt/Equity ratio of 1.00 indicates that WOK is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 1.00, WOK is doing worse than 74.46% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1
Debt/FCF N/A
Altman-Z 0.25
ROIC/WACCN/A
WACC5.44%
WOK Yearly LT Debt VS Equity VS FCFWOK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M -5M 10M -10M

2.3 Liquidity

  • WOK has a Current Ratio of 1.14. This is a normal value and indicates that WOK is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.14, WOK is not doing good in the industry: 85.87% of the companies in the same industry are doing better.
  • WOK has a Quick Ratio of 1.14. This is a bad value and indicates that WOK is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.98, WOK is doing worse than 78.26% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 0.98
WOK Yearly Current Assets VS Current LiabilitesWOK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. WOK Growth Analysis

3.1 Past

  • WOK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -278.50%.
  • WOK shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.89%.
  • The Revenue for WOK have been decreasing by -36.93% on average. This is quite bad
EPS 1Y (TTM)-278.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-95.02%
Revenue 1Y (TTM)8.89%
Revenue growth 3Y-36.93%
Revenue growth 5YN/A
Sales Q2Q%-14.42%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
WOK Yearly Revenue VS EstimatesWOK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

Find the best growth stocksShow best growing peers

0

4. WOK Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for WOK. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WOK Price Earnings VS Forward Price EarningsWOK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WOK Per share dataWOK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -500 -1K -1.5K -2K -2.5K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. WOK Dividend Analysis

5.1 Amount

  • WOK does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

WOK Fundamentals: All Metrics, Ratios and Statistics

WORK MEDICAL TECHNOLOGY GR-A

NASDAQ:WOK (3/16/2026, 2:13:44 PM)

1.14

+0.03 (+2.7%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-30
Earnings (Next)N/A
Inst Owners0.16%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.96M
Revenue(TTM)10.74M
Net Income(TTM)-3.71M
AnalystsN/A
Price TargetN/A
Short Float %5.62%
Short Ratio0.29
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.18
P/FCF N/A
P/OCF N/A
P/B 0.15
P/tB 0.16
EV/EBITDA N/A
EPS(TTM)-2873.8
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS6.24
BVpS7.53
TBVpS6.96
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -10.67%
ROE -28.62%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.88%
FCFM N/A
ROA(3y)-1.96%
ROA(5y)N/A
ROE(3y)-5.57%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.79%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 0.98
Altman-Z 0.25
F-ScoreN/A
WACC5.44%
ROIC/WACCN/A
Cap/Depr(3y)251.52%
Cap/Depr(5y)N/A
Cap/Sales(3y)31.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-278.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-95.02%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.89%
Revenue growth 3Y-36.93%
Revenue growth 5YN/A
Sales Q2Q%-14.42%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-170.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-806.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-200.83%
OCF growth 3YN/A
OCF growth 5YN/A

WORK MEDICAL TECHNOLOGY GR-A / WOK Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for WORK MEDICAL TECHNOLOGY GR-A?

ChartMill assigns a fundamental rating of 1 / 10 to WOK.


Can you provide the valuation status for WORK MEDICAL TECHNOLOGY GR-A?

ChartMill assigns a valuation rating of 0 / 10 to WORK MEDICAL TECHNOLOGY GR-A (WOK). This can be considered as Overvalued.


How profitable is WORK MEDICAL TECHNOLOGY GR-A (WOK) stock?

WORK MEDICAL TECHNOLOGY GR-A (WOK) has a profitability rating of 1 / 10.


What is the financial health of WORK MEDICAL TECHNOLOGY GR-A (WOK) stock?

The financial health rating of WORK MEDICAL TECHNOLOGY GR-A (WOK) is 1 / 10.